Search company, investor...

Predict your next investment

Venture Capital
westlakebio.com

See what CB Insights has to offer

Investments

18

Funds

3

About Westlake Village BioPartners

Westlake Village BioPartners is a Los Angeles area-based venture capital firm focused on incubating and building life sciences companies with entrepreneurs that have the potential to bring transformative therapies and technologies to patients.

Headquarters Location

3075 Townsgate Road Suite 140

Westlake Village, California, 91361,

United States

805-465-9588

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Westlake Village BioPartners News

Acelyrin Raises $300M Series C Financing

Sep 13, 2022

Acelyrin, a Los Angeles, CA-based late-stage clinical biopharma company, raised $300M in Series C funding. The round was led by Access Biotechnology with participation from existing investors AyurMaya – an affiliated fund of Matrix Capital Management, Westlake Village BioPartners, Cowen Healthcare Investments, Decheng Capital, Marshall Wace, OrbiMed, Samsara BioCapital, Surveyor Capital (a Citadel company), Tybourne Capital […] The post Acelyrin Raises $300M Series C Financing appeared first on FinSMEs.

Westlake Village BioPartners Investments

18 Investments

Westlake Village BioPartners has made 18 investments. Their latest investment was in ACELYRIN as part of their Series C on September 9, 2022.

CBI Logo

Westlake Village BioPartners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/13/2022

Series C

ACELYRIN

$300M

No

14

9/6/2022

Series B

ArsenalBio

$220M

No

11

8/25/2022

Series A

3T Biosciences

$40M

Yes

4

3/30/2022

Series C

Subscribe to see more

$99M

Subscribe to see more

10

2/16/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/13/2022

9/6/2022

8/25/2022

3/30/2022

2/16/2022

Round

Series C

Series B

Series A

Series C

Series A

Company

ACELYRIN

ArsenalBio

3T Biosciences

Subscribe to see more

Subscribe to see more

Amount

$300M

$220M

$40M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

14

11

4

10

10

Westlake Village BioPartners Fund History

3 Fund Histories

Westlake Village BioPartners has 3 funds, including Westlake BioPartners Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/15/2020

Westlake BioPartners Fund II

$430M

2

12/15/2020

Westlake BioPartners Opportunity Fund I

$99M

10

9/4/2018

Westlake BioPartners Fund I

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/15/2020

12/15/2020

9/4/2018

Fund

Westlake BioPartners Fund II

Westlake BioPartners Opportunity Fund I

Westlake BioPartners Fund I

Fund Type

Subscribe to see more

Status

Subscribe to see more

Amount

$430M

$99M

$99M

Sources

2

10

10

Westlake Village BioPartners Team

4 Team Members

Westlake Village BioPartners has 4 team members, including current Chief Operating Officer, Scott A Ryles.

Name

Work History

Title

Status

Scott A Ryles

Chief Operating Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Scott A Ryles

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Operating Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.